2017 n = 82 742 | 2018 n = 83 667 | 2019 n = 84 889 | 2020 n = 84 777 | 2021 n = 88 432 | |
---|---|---|---|---|---|
Female, n(%) | 47 617 (57.6) | 48 024 (57.4) | 48 911 (57.6) | 48 837 (57.6) | 50 976 (57.6) |
Age, median (IQR) | 61.0 (21.0) | 61.0 (20.0) | 61.0 (21.0) | 62.0 (21.0) | 61.0 (21.0) |
[40–64[ years, n(%) | 49 311 (59.6) | 49 232 (58.8) | 49 452 (58.3) | 48 380 (57.1) | 50 834 (57.5) |
[64–80[ years, n(%) | 24 221 (29.3) | 24 963 (29.8) | 25 627 (30.2) | 26 244 (31.0) | 27 292 (30.9) |
[80–100[ years, n(%) | 9 210 (11.1) | 9 472 (11.3) | 9 810 (11.6) | 10 153 (12.0) | 10 306 (11.7) |
LoS in days, median (IQR) | 4.0 (7.0) | 4.0 (7.0) | 4.0 (8.0) | 5.0 (9.0) | 5.0 (8.0) |
CVD Risk Category | |||||
Low-to-moderate risk, n(%) | 39 892 (48.2) | 39 441 (47.1) | 39 086 (46.0) | 37 743 (44.5) | 39 320 (44.5) |
High risk, n(%) | 18 573 (22.4) | 19 104 (22.8) | 19 868 (23.4) | 20 007 (23.6) | 20 791 (23.5) |
Very high risk, n(%) | 22 162 (26.8) | 23 094 (27.6) | 24 029 (28.3) | 24 693 (29.2) | 25 553 (28.9) |
- ASCVD, n(%) | 9 290 (11.2) | 9 493 (11.3) | 9 456 (11.1) | 9 516 (11.2) | 9 720 (11.0) |
- ASCVD-risk equivalent, n(%) | 12 872 (15.6) | 13 656 (16.3) | 14 573 (17.2) | 15 177 (17.9) | 15 833 (17.9) |
Risk category unknown | 2 115 (2.6) | 2 028 (2.4) | 1 906 (2.2) | 2 334 (2.8) | 2 768 (3.1) |
Number of episodes | |||||
Hospital admissions, n(%) | 8 560 (1.3) | 8 309 (1.3) | 8 125 (1.3) | 7 120 (1.2) | 7 660 (1.2) |
Hospital outpatient visits, n(%) | 161 925 (25.4) | 160 862 (25.4) | 156 564 (24.5) | 129 350 (22.5) | 154 437 (24.6) |
Emergency visits, n(%) | 44 205 (6.9) | 41 145 (6.5) | 42 560 (6.7) | 38 549 (6.7) | 42 058 (6.7) |
Primary care scheduled visits, n(%) | 355 716 (55.7) | 356 582 (56.2) | 363 873 (57.0) | 374 882 (65.2) | 407 430 (65.0) |
Primary care unscheduled visits, n(%) | 67 747 (10.6) | 67 322 (10.6) | 67 311 (10.5) | 25 001 (4.3) | 15 402 (2.5) |